Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Virtual Clinical Trials Market

Virtual Clinical Trials Market Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology AND Others), End User (Hospitals, Clinics, Ambulatory Centers and Others) Design (Observational Trials, Interventional Trials and Expanded Access Trials): Global Opportunity Analysis and Industry Forecast, 2021–2030.

A14309
Pages: NA
Jan 2022 | 27 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Virtual Clinical Trials Market

Request Now !

Virtual Clinical Trials (VCTs), which are also called as decentralized or remote trials, are a comparatively new and yet underutilized process of conducting clinical research, taking full benefit of advancements of technology like electronic monitoring devices, applications, and online social engagement platforms.

Virtual trials, also known as decentralized trials, have an important role to play in the present situation of the COVID-19 crisis and are yet to become a norm in the way real-world studies and trials are run. The virtual method helps individuals to take part in the trial from their residence, ensuring that the trials can be conducted and continued even the visit to the actual site physically is not possible. Also, it is a completely unique method to collect effective and safe data from participants of clinical studies.

Virtual studies enable sponsors to attract a bigger population to the study, thus improving engagement, recruitment, and retention. In addition, it enables to continue the real-time collection of data by digital health technology. Eventually, connecting virtually, monitoring as well as management can decrease the hassle, burden on participants, CRCs, and investigators.

Virtual Clinical Trials Market Scope and Structure Analysis

Report Metric 

Details

 Market size available for years

 2020–2030

  Base year considered

  2020

  Forecast period

  2021–2030

  Forecast units

  Value (USD)

  Segments covered

  Indication, End User, Design, and Region

  Geographies covered

North America (U.S., Canada, and Mexico), Europe (Germany, France, U.K., Italy, Spain and the Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa and the Rest of LAMEA)

 Companies covered

Major players analyzed include PRA Health Sciences, Medidata, IQVIA, Medable, Inc., LEO Innovation Lab, Clinical Ink, Covance, CRF Health, Parexel International Corporation, ICON Plc.

 

Impact of COVID-19 Pandemic on Virtual Clinical Trials Market (Pre and Post Analysis)

  • The outbreak of COVID-19 is likely to have a moderate impact on the market in the forecast period. R&D activities to identify the threat of SARS-CoV-2 virus on the patients suffering are likely to slow the virtual clinical trials market growth.
  • COVID-19 pandemic has brought about a significant burden on the healthcare industry globally, with disruption in the treatment of non-communicable diseases. Challenges exist in providing effective care.
  • Realizing the disturbing healthcare trends, governments globally are making efforts to provide excellent quality healthcare to patients globally. Nationwide lockdowns, canceled or postponed elective surgeries, denied wound care services, rise in skin injuries as part of COVID-19, the market is expected to show a decline during the forecast timeline. However, on the flip side, the latter half of the forecast is predicted to show a drastic rise.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The COVID-19 pandemic has made a huge impact on the global as well as domestic market. Several trials that are primarily made for traditional settings are being mandatory to change to virtual trails platform.
Patients with cancer are highly susceptible during the COVID-19. Sponsors and investigators are managing clinical trials on oncology virtually and remote trials to keep the individuals safe and keep the trials in the process. Regulatory agencies and biopharma companies are focused on the creation of virtual trials, digital technologies, and telemedicine, as they are capable of solutions to limit the disruptions in trials. The Food & Drug Administration has suggested remote checking and virtual visits via telemedicine as an alternate option to in-person visits.
Therefore, the companies are emphasizing to bring in the change via advancements in technology to rapidly fulfill augmenting healthcare digitalization. 
For example, Johnson & Johnson, in February 2020, initiated a virtual design Heartline study to check whether the iPhone app or iPhone watch could reduce the chance of stroke discovering cardiac arrhythmia.
In addition, technological advancements in the healthcare industry are predicted to fuel the overall market. Direct delivery of Investigational medicinal products (IMPs) to patients is decentralized trials (virtual), which has gained immense popularity for the last many years. It is anticipated to boost the worldwide virtual clinical trials market. Large amounts of data, technological failure, data accuracy and prove and reliability to reliability to regulators are some of the challenges that are witnessed to restrain the virtual clinical trials market globally.
North America is dominated the virtual clinical trial’s market globally because of the rise in investments from the public as well as private players and the contribution of core market leaders for enhanced virtual trial solutions. It accounted for a prominent share in the virtual clinical trials market globally in terms of revenue, due increase in R&D activities in the region, increasing rate of adoption of technology in the region in the clinical region, and government support. Also, market players are adopting digital technologies to interact with clients.
Asia-Pacific followed by Europe is witnessed lucrative growth and holding a notable share in the market owing to a rapid increase in the number of experiments to adopt new medications for different diseases as well as the digitalization of laboratories.


Key Segments Covered

Segments

Sub-segments

  Indication

  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology
  • Others

  End User

  • Hospitals
  • Clinics
  • Ambulatory Centers
  • Other

  Design

  • Observational Trials
  • Interventional Trials
  • Expanded Access Trials

 

Key Benefits of the Report

  • This study presents the analytical depiction of the global virtual clinical trials market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global virtual clinical trials market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the global virtual clinical trials market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global virtual clinical trials market analysis based on competitive intensity and how the competition will take shape in the coming years. 

Questions Answered in the Report

  • What are the leading market players active in the virtual clinical trials market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the virtual clinical trials market?
  • What are the projections for the future that would help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Virtual Clinical Trials Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers